| scholarly article | Q13442814 |
| P50 | author | Anne Janin | Q60963223 |
| Jean-Paul Feugeas | Q115606253 | ||
| Philippe Ratajczak | Q115606254 | ||
| Morad El Bouchtaoui | Q115606271 | ||
| Guillaume Gapihan | Q115606287 | ||
| Catherine Thieblemont | Q41604017 | ||
| P2093 | author name string | Li Wang | |
| Carlos Saavedra | |||
| Luis Jaime Castro-Vega | |||
| Martha Romero | |||
| Mélanie Di Benedetto | |||
| Andrés Acevedo | |||
| Zhao Wei Li | |||
| P2860 | cites work | FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells | Q24304887 |
| Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 | ||
| miRiad roles for the miR-17-92 cluster in development and disease | Q24646970 | ||
| Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes | Q24651802 | ||
| Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways | Q24652565 | ||
| Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma | Q24672476 | ||
| A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma | Q24680233 | ||
| The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas | Q26992198 | ||
| The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease | Q27015587 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| MicroRNAs in B-cell lymphomas: how a complex biology gets more complex | Q28254647 | ||
| The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study | Q44875676 | ||
| t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma. | Q52857151 | ||
| Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study. | Q52887085 | ||
| Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma. | Q53606604 | ||
| The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. | Q53931762 | ||
| Gains ofREL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein | Q61312181 | ||
| Primary mediastinal large B-cell lymphoma | Q87189737 | ||
| A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy | Q28256358 | ||
| A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation | Q28280072 | ||
| T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma | Q28306819 | ||
| Foxp1 is an essential transcriptional regulator of B cell development | Q28586790 | ||
| BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas | Q29622911 | ||
| Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494. | Q33832087 | ||
| Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas | Q33940931 | ||
| Primary mediastinal large B-cell lymphoma | Q34266819 | ||
| The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma | Q34456199 | ||
| Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma | Q34517305 | ||
| Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab | Q34679166 | ||
| Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy | Q35039281 | ||
| Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma | Q35080097 | ||
| Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma | Q35095028 | ||
| The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression | Q35551567 | ||
| Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer | Q35782978 | ||
| Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis | Q36010283 | ||
| Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma | Q36057764 | ||
| mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer | Q36103305 | ||
| Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1. | Q36563205 | ||
| CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study | Q36979534 | ||
| A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. | Q37229105 | ||
| The molecular pathogenesis of primary mediastinal large B-cell lymphoma | Q37893841 | ||
| The forkhead transcription factor FOXP1 represses human plasma cell differentiation | Q38842444 | ||
| Deregulated FOX genes in Hodgkin lymphoma | Q38973626 | ||
| Downregulation of FOXP1 is required during germinal center B-cell function. | Q39167447 | ||
| MicroRNA 17-92 expressed by a transposone-based vector changes expression level of cell-cycle-related genes | Q39325636 | ||
| The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation | Q39437383 | ||
| Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1 | Q39565441 | ||
| The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma | Q39621978 | ||
| MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes | Q39926867 | ||
| Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study | Q43270033 | ||
| Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients. | Q43655408 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | B-cell lymphoma | Q4833719 |
| primary mediastinal B-cell lymphoma | Q53660452 | ||
| P304 | page(s) | 16243-16258 | |
| P577 | publication date | 2016-10-28 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting | |
| P478 | volume | 8 |
Search more.